A Modular Biomimetic Nanovaccine for TBEV: Orchestrating Cascade Immunoprotection via Programmed Dendritic Cell Targeting and Antigen–Adjuvant Co-delivery
ACS Infectious Diseases · 09.10.2026 · 12 (10) · 3487-3501
DOI: 10.1021/acsinfecdis.6c00544 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 16.09.2026. Verfasst von Names Yuancheng Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Educ…. Hauptthemen laut MEDLINE: Dendritic Cells, Encephalitis Viruses, Tick-Borne, Encephalitis, Tick-Borne, Viral Vaccines. Die Arbeit nennt 63 Literaturangaben. Gefördert von: Jilin Provincial Scientific and Technological Development Program, National Basic Research Program of China (973 Program).
Abstract (Originalsprache)
Tick-borne encephalitis (TBE) is an escalating global health threat, increasingly exacerbated by climate change, and underscores the need for innovative vaccine strategies. Conventional subunit vaccines are limited by suboptimal spatiotemporal dissociation between antigens and adjuvants, as well as insufficient specific targeting, resulting in compromised immunogenicity. Herein, we report a biomimetic nanovaccine platform engineered to overcome these limitations through the synergistic co-delivery of antigen and adjuvant. This platform is constructed by co-displaying the TBE virus envelope protein domain III (fused to a dendritic cell-targeting peptide, Dcpep) together with the molecular adjuvant MAB2560 on the surface of bacterium-like particles (BLPs). The resulting co-display vaccine, EDc2&MAB2560-GEM BLPs, outperforms a simple mixture of its components, inducing significantly higher titers of TBEV-specific IgG antibodies, robust T-cell and B-cell immune responses, and durable immunity in mice. Mechanistic studies reveal that these enhanced immune responses arise from the platform’s ability to precisely co-deliver antigen and adjuvant to dendritic cells, thereby triggering a potent cascading immunostimulatory effect. This work highlights the critical role of spatiotemporal coupling within targeted nanocarriers and establishes a versatile strategy for the development of next-generation subunit vaccines with enhanced potency and safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jili…
ORCID-Profile: Yuanyuan Li
Förderung
- Jilin Provincial Scientific and Technological Development Program
- National Basic Research Program of China (973 Program)
Zitieren
APA
Li, N. Y., Miao, K., Zhang, M., Li, H., Wang, D., Xie, X., Wang, H., & Li, Y. (2026). A Modular Biomimetic Nanovaccine for TBEV: Orchestrating Cascade Immunoprotection via Programmed Dendritic Cell Targeting and Antigen–Adjuvant Co-delivery. ACS Infectious Diseases, 12(10), 3487-3501. https://doi.org/10.1021/acsinfecdis.6c00544
Vancouver
Li NY, Miao K, Zhang M, Li H, Wang D, Xie X, et al. A Modular Biomimetic Nanovaccine for TBEV: Orchestrating Cascade Immunoprotection via Programmed Dendritic Cell Targeting and Antigen–Adjuvant Co-delivery. ACS Infectious Diseases. 2026;12(10):3487-3501. doi:10.1021/acsinfecdis.6c00544
BibTeX
@article{Li2026,
author = {Li, Names Yuancheng and Miao, Kunrong and Zhang, Mengyao and Li, Hailun and Wang, Di and Xie, Xiaohan and Wang, Hualei and Li, Yuanyuan},
title = {A Modular Biomimetic Nanovaccine for TBEV: Orchestrating Cascade Immunoprotection via Programmed Dendritic Cell Targeting and Antigen–Adjuvant Co-delivery},
journal = {ACS Infectious Diseases},
year = {2026},
volume = {12},
number = {10},
pages = {3487--3501},
doi = {10.1021/acsinfecdis.6c00544}
}
EUVIMED